(Q28505165)

24 January 2017

title

Efficient influenza B virus propagation due to deficient interferon-induced antiviral activity in MDCK cells (English)

1 reference

24 January 2017

main subject

MX dynamin-like GTPase 1

1 reference

GOA release 2020-03-11

Influenza B virus

object named as

influenza B virus

1 reference

6

Udo Reichl

1 reference

24 January 2017

Timo Frensing

1

1 reference

24 January 2017

Claudius Seitz

2

1 reference

24 January 2017

Bjoern Heynisch

3

1 reference

24 January 2017

Corinna Patzina

4

1 reference

24 January 2017

Georg Kochs

5

1 reference

24 January 2017

language of work or name

English

0 references

publication date

22 September 2011

1 reference

24 January 2017

1 reference

24 January 2017

volume

29

1 reference

24 January 2017

issue

41

1 reference

24 January 2017

page(s)

7125–7129

1 reference

Continuous cell lines as a production system for influenza vaccines.

24 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.069

Differential susceptibility of different cell lines to swine-origin influenza A H1N1, seasonal human influenza A H1N1, and avian influenza A H5N1 viruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.069

Trivalent MDCK cell culture-derived influenza vaccine Optaflu (Novartis Vaccines).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.069

The interferon response circuit: induction and suppression by pathogenic viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.069

Interplay between influenza A virus and the innate immune signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.069

IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.069

Mice lacking the ISG15 E1 enzyme UbE1L demonstrate increased susceptibility to both mouse-adapted and non-mouse-adapted influenza B virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.069

High yields of influenza A virus in Madin-Darby canine kidney cells are promoted by an insufficient interferon-induced antiviral state.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.069

Intracellular warfare between human influenza viruses and human cells: the roles of the viral NS1 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.069

Species specificity of the NS1 protein of influenza B virus: NS1 binds only human and non-human primate ubiquitin-like ISG15 proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.069

Species-specific antagonism of host ISGylation by the influenza B virus NS1 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.069

Metabolism of MDCK cells during cell growth and influenza virus production in large-scale microcarrier culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.069

Monitoring influenza virus content in vaccine production: precise assays for the quantitation of hemagglutination and neuraminidase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.069

The central interactive region of human MxA GTPase is involved in GTPase activation and interaction with viral target structures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.069

Peptide-mediated interference with influenza A virus polymerase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.069

Influenza A virus strains differ in sensitivity to the antiviral action of Mx-GTPase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.069

Rhabdovirus evasion of the interferon system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.069

Susceptibility of Influenza Viruses to Interferon and to Poly (I) · Poly (C) Determined by the Plaque Reduction Method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.069

Lethal H5N1 influenza viruses escape host anti-viral cytokine responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.069

The influence of cortisone on experimental viral infection. VII. Kinetics of interferon formation and its inhibition with hydrocortisone in relation to viral strain and virulence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.069

Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.069

Maturation efficiency of viral glycoproteins in the ER impacts the production of influenza A virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.069

Replication fitness determines high virulence of influenza A virus in mice carrying functional Mx1 resistance gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.069

Growth determinants for H5N1 influenza vaccine seed viruses in MDCK cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.069

10.1016/J.VACCINE.2011.05.069

7 January 2021

Identifiers

DOI

0 references

1 reference